Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Smethurst

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Lancet (London, England)|September 26, 1987
Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugsI Bjarnason, G Zanelli, P Prouse, et al.
Gastroenterology|September 1, 1987
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humansI Bjarnason, G Zanelli, T Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2012
First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind studyGeorge D Demetri, Axel Le Cesne, Sant P Chawla, et al.
Blood|June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanomaGerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Lancet (London, England)|September 26, 1987
Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugsI Bjarnason, G Zanelli, P Prouse, et al.
Gastroenterology|September 1, 1987
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humansI Bjarnason, G Zanelli, T Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2012
First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind studyGeorge D Demetri, Axel Le Cesne, Sant P Chawla, et al.
Blood|June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanomaGerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Pageof 4